AI assistant
LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2016
Nov 22, 2016
32814_dirs_2016-11-22_23b713bd-af49-48d5-a58d-d1717e02b478.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK: 0001062822
Period of Report: 2016-11-17
Reporting Person: Santini Alexander A (EVP and CCO)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $8.20 | 2026-02-11 | Common Stock (21960) | Direct | |
| Restricted Stock Units (Phantom Stock) | $ | Common Stock (9410) | Direct | ||
| Stock Option (Right to Buy) | $7.21 | 2025-04-20 | Common Stock (18571) | Direct |
Footnotes
F1: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/11/2017) and vests 1/48th per month for each month of service thereafter.
F2: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.
F3: Each restricted stock unit represents a contingent right to receive one share of common stock.
F4: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (4/20/2016) and vests 1/48th per month for each month of service thereafter.